跳至主要内容
临床试验/EUCTR2006-005533-38-NL
EUCTR2006-005533-38-NL进行中(未招募)1 期

'Studies in patients with chronic cough; montelukast and amitriptyline studies’. - chronic cough studies.

there is no sponsor.0 个研究点开始时间: 2006年10月20日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Montelukast study:
  • 1. patients between 16 and 90 years old, referred to the cough
  • outpatient clinic with chronic cough and enhanced bronchial
  • hyperreactivity.
  • 2. chronic cough is defined as a cough > 8 weeks duration.
  • 3. enhanced bronchial hyperreactivity is a PD20 < 2.5 mg metacholine.
  • 1. amitriptyline study: patients between 16-90 years with no discernible
  • cause for coughing.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • both studies:
  • 1. concomitant severe disease.
  • 2. patients suffering from COPD and / or other relevant lung diseases.
  • 3. clinically relevant abnormal laboratory values suggesting an unknown disease
  • requiring further clinical evaluation.
  • 4. use of systemic steroids 4 weeks (injectable depot steroids 6 weeks) before
  • entry into the baseline period, or more than 3 courses during the last 6 months.
  • 5. pregnancy.
  • 6. abnormal chest X-ray.
  • 7. intolerance to either montelukast or to amitriptyline in either study.

研究者

发起方
there is no sponsor.

相似试验

'Studies in patients with chronic cough; montelukast... | 临床试验